Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Posted on February 4, 2026

By Rashmi Gulati

Fetal Viability by Week

Fetal Viability Week by Week: When Can a Baby Survive Outside the Womb?

Written by Shweta Rathod, MD — Doctor of Medicine, clinical experience in Obstetrics & Gynecology, labour room management, and IVF. Dr. Rathod writes Surrogacy4All’s pregnancy and obstetric content.
Medically reviewed by Rashmi Gulati, MD — Board Certified, Internal Medicine; Medical Advisor, Surrogacy4All; privileges at Mount Sinai Hospital.
Last updated: 27 August  2026

AI Smart Summary

Fetal viability — a reasonable chance of survival outside the womb with intensive care — is generally placed at 24 weeks; many NICUs offer active treatment from 22–23 weeks. Survival with active treatment is roughly 10–30% at 22 weeks, 30–55% at 23, 55–70% at 24, 70–80% at 25, and 90–95% by 28 weeks (NICHD Neonatal Research Network cohorts). This page is written by an OB-GYN and reviewed by Surrogacy4All’s Medical Director; Surrogacy4All is a NYS-licensed, physician-led agency operating since 2006.

FAST FACTS

Fact Value
Conventional viability 24 weeks
Periviable period (ACOG/SMFM) 22w0d – 25w6d
Survival at 24 weeks ≈ 55–70% with active treatment (NICHD NRN)
Survival at 28 weeks ≈ 90–95%
Author / reviewer Shweta Rathod, MD / Rashmi Gulati, MD
License / registration GSP220903, FDA FEI #3021544308
Locations New York, Toronto, Accra
Fetal viability — the point at which a baby has a reasonable chance of surviving outside the womb with intensive care — is generally placed at 24 weeks of pregnancy. Many NICUs now offer active treatment from 22 to 23 weeks, and survival rises steeply each week: roughly one in three at 23 weeks, more than half at 24, and about nine in ten by 27–28 weeks.
This page gives the survival rates week by week from the largest US datasets, explains what “viability week” means clinically and legally, what changes a particular baby’s odds, and how viability applies to IVF and surrogacy pregnancies. It is reviewed by our Medical Director.

Survival by week of gestation

Week Approx. survival with active treatment Notes
21 < 5% Intensive treatment rarely offered
22 10–30% Offered at some Level IV NICUs; depends heavily on center
23 30–55% Steroids and NICU level matter most here
24 55–70% Conventional viability threshold
25 70–80%
26 80–90%
27 ~90%
28 90–95% Survival without major complications ≈ 80%
32 > 95%
34+ ≈ 99% “Late preterm”
The figures are approximate ranges drawn from the NICHD Neonatal Research Network and published cohort studies of infants who received active treatment, and they vary by hospital: a Level IV NICU with a periviability program will report higher survival at 22–23 weeks than a community hospital. Survival without major complications lags survival by one to two weeks.

What “viability week” means

Clinicians use viability to decide whether to offer intensive treatment at birth, whether to give antenatal steroids and magnesium, and whether to deliver early for the mother’s health. ACOG and the Society for Maternal-Fetal Medicine describe 22 weeks 0 days to 25 weeks 6 days as the periviable period, in which decisions are individualized with the parents.
Legally, some US states use “viability” as a threshold in abortion law, usually placing it at 22–24 weeks; the legal definition does not change the medical one. This page addresses the medical meaning.

What improves a baby’s chances at the edge of viability

  • Antenatal corticosteroids (betamethasone) given to the mother before delivery
  • Magnesium sulfate for neuroprotection
  • Delivery at a hospital with a Level III or IV NICU rather than transfer after birth
  • Higher birth weight and female sex (statistically)
  • Singleton pregnancy
  • Each additional day in utero — the reason obstetricians work to delay preterm labor even by 48 hours

Viability in IVF and surrogacy pregnancies

Pregnancies from frozen embryo transfer are dated from the transfer, so gestational age is known to the day, which makes viability decisions more precise. Single embryo transfer reduces the chance of a preterm twin delivery, which is the most common route to a periviable birth in assisted reproduction. Our gestational carrier agreements address decisions in the periviable period in advance so that the surrogate and the intended parents have agreed how they will be made.

Related tools

Our miscarriage risk estimator, IVF due date calculator and week-by-week baby position guide are linked below.

Frequently Asked Questions

Q. What week is viability in pregnancy?

A. About 24 weeks is considered the conventional threshold for viability. However, active neonatal care may be offered from 22–23 weeks at some hospitals, depending on the hospital’s resources and periviability program.

Q. When is viability week?

A. The 24th week of pregnancy is the conventional viability threshold. The periviable period is generally defined as 22 weeks 0 days through 25 weeks 6 days.

Q. What is the survival rate at 24 weeks?

A. Approximately 55–70% of babies born at 24 weeks may survive with active treatment in a Level III or Level IV NICU. Outcomes vary based on the baby’s condition, birth weight, treatments provided, and the hospital’s experience.

Q. What is the survival rate at 22 weeks?

A. Survival at 22 weeks is approximately 10–30% in centers where active treatment is offered. Many hospitals make individualized decisions about whether intensive treatment is appropriate at this gestational age.

Q. When is a fetus viable?

A. A fetus is considered viable when there is a possibility of survival outside the womb with intensive neonatal care. In practice, this generally begins around 22–24 weeks, although outcomes vary significantly from one pregnancy and medical center to another.

Q. What is the age of viability?

A. 24 weeks is commonly considered the conventional age of viability. Some hospitals with specialized periviability programs may offer active treatment at 22–23 weeks.

Q. Is a baby born at 25 weeks likely to survive?

A. Yes. With active neonatal treatment, survival at 25 weeks is approximately 70–80%, although babies born this early can still face complications associated with extreme prematurity.

Q. At 28 weeks, is the baby safe?

A. Survival at 28 weeks is approximately 90–95% with appropriate neonatal care. However, being born at 28 weeks is still considered very preterm, and complications related to prematurity remain possible.

Q. Does viability apply to IVF pregnancies differently?

A. No. The general principles of viability are the same for IVF pregnancies. However, gestational dating is particularly precise in IVF, because the pregnancy can be dated using the embryo transfer date and embryo age. Single-embryo transfer can also reduce the risk of multiple pregnancy and associated early preterm birth.

Q. Can a fetus survive at 20 or 21 weeks?

A. Survival at 20–21 weeks is extremely rare. Most hospitals do not routinely offer intensive neonatal treatment at these gestational ages because the likelihood of survival is very low.

Q. What is the earliest a baby has survived?

A. Case reports of survival at 21 weeks have been published, but survival at this gestational age remains extremely rare. Most hospitals do not routinely offer intensive treatment at 21 weeks.

Q. Why is 24 weeks considered the viability threshold?

A. Around 24 weeks, survival with active neonatal care reaches approximately 50% or higher in some large U.S. cohorts. This has contributed to 24 weeks becoming the conventional threshold for viability, although decisions are individualized.

Q. What are the long-term outcomes at 23–24 weeks?

A. Long-term outcomes vary considerably. Among survivors born at 23–24 weeks, some have no or only mild impairment, while others experience moderate to severe complications. Outcomes generally improve with each additional week of pregnancy.

Q. Do steroids help before 24 weeks?

A. Yes. Antenatal corticosteroids may improve outcomes for babies born extremely preterm, including at 22–23 weeks when active neonatal treatment is planned. The timing and use of steroids should be determined by the obstetric and neonatal care teams.

Q. How is gestational age calculated in IVF?

A. In IVF pregnancies, gestational age is calculated using the embryo transfer date and the age of the embryo at transfer. For example, a blastocyst transferred at five days of development is incorporated into the pregnancy dating calculation, making IVF gestational dating highly precise.

Q. Is viability different for twins?

A. The basic viability principles are similar, but twins are more likely to be born prematurely. Survival at a particular gestational age can be similar, while the overall risk of a periviable birth is higher in twin pregnancies.

Q. What is the difference between viability and full term?

A. Viability refers primarily to the possibility of surviving outside the womb with medical support and is conventionally around 24 weeks. Full term refers to a pregnancy reaching 39–40 weeks, when the baby is considered mature enough for normal delivery timing.

Q. What is a Level IV NICU?

A. A Level IV NICU provides the highest level of neonatal intensive care and has advanced medical, surgical, and subspecialty capabilities. These centers are generally best equipped to care for babies born at extremely early gestational ages, including those in the 22–24-week range.

Q. How do doctors decide whether to resuscitate at 22 weeks?

A. The decision is individualized and made together with the parents and medical team. Factors may include gestational age, estimated birth weight, the baby’s condition, antenatal steroid treatment, sex, and the hospital’s experience and periviability program.

Q. How does viability affect a surrogacy contract?

A. Decisions regarding care during the periviable period should be discussed with the intended parents, surrogate, and appropriate medical and legal professionals before embryo transfer. These discussions can help clarify expectations and ensure that relevant medical decisions are addressed in the surrogacy agreement.

Building your family through IVF or surrogacy?

Our physicians answer questions — free consultation, (212) 661-7673.

Written by Shweta Rathod, MD — Doctor of Medicine with clinical experience in Obstetrics & Gynecology, labor room management, and IVF. Dr. Rathod writes pregnancy and obstetric content for Surrogacy4All.

Medically reviewed by Rashmi Gulati, MD — Board Certified in Internal Medicine and Medical Advisor at Surrogacy4All, with privileges at Mount Sinai Hospital.

Last updated: 27 Aug 2026 

Meet our team →

Surrogacy4All · DGA, Inc. · 1148 5th Ave 1C, New York, NY 10128 · (212) 661-7673 · info@surrogacy4all.com · NYS Surrogacy Program License GSP220903 · NYS Tissue Bank License ID 1570 · FDA-registered (FEI 3021544308) · Clinics in New York, Toronto and Accra.
Rashmi Gulati

Rashmi Gulati, MD, provides innovative, individualized health care that nurtures mind, body, and spirit. Since 2004 she has been the medical director at Patients Medical, where she delivers comprehensive personalized health care, treating each patient as a respected, unique individual. Through their integrative health care center in the heart of Manhattan, Dr. Gulati and her colleagues have become premier care providers serving patients locally and throughout the world.